Who are Biofrontera Inc.'s main suppliers?

Biofrontera Inc. (BFRIW) key suppliers include: ORANY, ORANY. View the full supplier network at chainsifter.com/chain/BFRIW.

Who are Biofrontera Inc.'s major customers?

Biofrontera Inc. (BFRIW) key customers include: ORANY, ORANY. View the full customer network at chainsifter.com/chain/BFRIW.

What sector is Biofrontera Inc. in?

Biofrontera Inc. (BFRIW) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Biofrontera Inc. (BFRIW) Suppliers & Customers

2Suppliers

2Customers

2Debt Items

20Related Chains

Source-Backed Evidence Depth

Biofrontera Inc. (BFRIW) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

6Total relationships

1Distinct source URLs

2High confidence

0.780Average confidence

2026-09-27Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Biofrontera Inc. Suppliers

Ticker	Name	Confidence	Evidence
ORANY	ORANY	72%	2040. Furthermore, in 2023, the FDA approved a new formulation of Ameluz ® that lacks propylene glycol and reduces the accumulation of certain contaminants over time. The new formulation was implemen…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from BFRIW graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from BFRIW graph: Reciprocal relationship from OR…

Biofrontera Inc. Customers

Ticker	Name	Confidence	Evidence
ORANY	ORANY	72%	2040. Furthermore, in 2023, the FDA approved a new formulation of Ameluz ® that lacks propylene glycol and reduces the accumulation of certain contaminants over time. The new formulation was implemen…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from BFRIW graph: 2040. Furthermore, in 2023, the FDA approved a new formulation of Ameluz ® that lacks propylene glycol and reduces …

Biofrontera Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
BFRIW-DEBT-8164	Warrants outstanding: 100	90%	xbrl warrant detail from xbrl 2024-12-31.
BFRIW-DEBT-8165	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2024-12-31.

Biofrontera Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Biofrontera Inc..

Biofrontera Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Biofrontera Inc..

Biofrontera Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
ORANY	ORANGE	100.00	1	['customer', 'supplier']
BCDRF	Banco Santander, S.A.	50.00	2
CHUC	Charlie's Holdings, Inc.	50.00	2
BFRGW	BullFrog AI Holdings, Inc.	50.00	2
AMZE	Amaze Holdings, Inc.	50.00	2
CPRX	Catalyst Pharmaceuticals, Inc.	50.00	2
AYTU	Aytu BioPharma, Inc.	50.00	2
CYCN	Cyclerion Therapeutics, Inc.	50.00	2
D	Dominion Energy, Inc.	50.00	2
EPDU	ENTERPRISE PRODUCTS PARTNERS L.P.	50.00	2
CINGW	Cingulate Inc.	50.00	2
DARE	Daré Bioscience, Inc.	50.00	2
CANF	Can-Fite BioPharma Ltd.	50.00	2
DFTX	Definium Therapeutics, Inc.	50.00	2
ASBPW	Aspire Biopharma Holdings, Inc.	50.00	2
CLNE	Clean Energy Fuels Corp.	50.00	2
FENC	Fennec Pharmaceuticals Inc.	50.00	2
EQR	Equity Residential	50.00	2
CNOB	ConnectOne Bancorp, Inc.	50.00	2
BLTE	Belite Bio, Inc	50.00	2

Biofrontera Inc. Supply Chain